{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:24:43Z","timestamp":1767857083846,"version":"3.49.0"},"reference-count":28,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 EB007958"],"award-info":[{"award-number":["U54 EB007958"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U-01068613"],"award-info":[{"award-number":["U-01068613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The increasing rates of gonorrhea infections and the global emergence and spread of multi-drug-resistant Neisseria gonorrhoeae (NG) threaten the successful management of gonorrhea. In the era of nucleic acid amplification tests (NAATs), surveillance projects are urgently needed to monitor prevalence and trends in the antimicrobial susceptibility of NG. In this study, we retrospectively determined the susceptibility profile of NG isolates to previously and currently prescribed antimicrobials. NG isolates collected in Baltimore, Maryland between January and October 2016 were evaluated by the E-test method and\/or molecular methods for susceptibility to ceftriaxone, azithromycin, ciprofloxacin, tetracycline, gentamicin, and penicillin. One-hundred and forty-three NG isolates from African-American males (98.6%), primarily heterosexual (88.8%), ranging in age from 15 to 69 years of age were included in the study. Ciprofloxacin resistance was observed in 44.1% of isolates. Plasmid-mediated resistance to penicillin and tetracycline resistance was detected in 22.4% and 10.1% of isolates, respectively. Three isolates (2.1%) displayed high-level resistance to azithromycin (minimum inhibitory concentration (MIC) &gt; 256 \u03bcg\/mL). Forty-three percent of isolates were resistant or had decreased susceptibility to three antimicrobials (ciprofloxacin, tetracycline, and penicillin). All isolates were susceptible to ceftriaxone and gentamicin. Overall, the epidemiology of antimicrobial resistant NG in Baltimore continues to evolve, and the emergence of azithromycin resistance in this population emphasizes the need for continued sentinel surveillance programs to monitor susceptibility trends and aid in treatment recommendations.<\/jats:p>","DOI":"10.3390\/antibiotics7030077","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T10:54:25Z","timestamp":1534503265000},"page":"77","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Baltimore, Maryland, 2016: The Importance of Sentinel Surveillance in the Era of Multi-Drug-Resistant Gonorrhea"],"prefix":"10.3390","volume":"7","author":[{"given":"Johan H.","family":"Melendez","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Hardick","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilda","family":"Barnes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen R.","family":"Page","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N., Unemo, M., Low, N., Stevens, G., Gottlieb, S., Kiarie, J., and Temmerman, M. (2015). Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143304"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by Neisseria gonorrhoeae: A major global public health problem in the 21st century","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_3","first-page":"1","article-title":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm. Rep."},{"key":"ref_4","unstructured":"(2018, July 01). WHO Guidelines for the Treatment of Neisseria gonorrhea. Available online: http:www.who.int\/reproductivehealth\/publications\/rtis\/gonorrhoea-treatment-guidelines\/en\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref_6","unstructured":"(2018, July 01). Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. Available online: http:www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill. Summ."},{"key":"ref_9","unstructured":"(2018, June 25). STI Data & Statistics, Available online: https:\/\/phpa.health.maryland.gov\/OIDPCS\/CSTIP\/Pages\/STI-Data-Statistics.aspx."},{"key":"ref_10","unstructured":"(2018, June 28). 2013 Sexually Transmitted Diseases Surveillance, Available online: https:\/\/www.cdc.gov\/std\/gisp2013\/default.htm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.olq.0000154495.24519.bf","article-title":"Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae","volume":"32","author":"Tabrizi","year":"2005","journal-title":"Sex. Transm. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/OLQ.0000000000000755","article-title":"Molecular characterization of markers associated with antimicrobial resistance in Neisseria gonorrhoeae identified from residual clinical samples","volume":"45","author":"Melendez","year":"2018","journal-title":"Sex. Transm. Dis."},{"key":"ref_13","first-page":"100","article-title":"Clinical and laboratory standard institute. performance standards for antimicrobial susceptibility testing","volume":"31","author":"Wayne","year":"2011","journal-title":"Inform. Suppl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/AAC.04337-14","article-title":"Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013","volume":"59","author":"Kirkcaldy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"Brown","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/dkq476","article-title":"An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe","volume":"66","author":"Chisholm","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/OLQ.0000000000000693","article-title":"Susceptibility of Neisseria gonorrhoeae to gentamicin-gonococcal isolate surveillance project, 2015\u20132016","volume":"45","author":"Mann","year":"2018","journal-title":"Sex. Transm. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/jcm.9.2.205-207.1979","article-title":"Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria","volume":"9","author":"Montgomery","year":"1979","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/JCM.42.7.3281-3283.2004","article-title":"Use of applied biosystems 7900HT sequence detection system and TaqMan assay for detection of quinolone-resistant Neisseria gonorrhoeae","volume":"42","author":"Giles","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/JCM.02024-10","article-title":"Enhancing gonococcal antimicrobial resistance surveillance: A real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of non-cultured clinical samples","volume":"49","author":"Goire","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cole, M.J., Spiteri, G., Jacobsson, S., Woodford, N., Tripodo, F., Amato-Gauci, A.J., Unemo, M., and Euro-GASP Network (2017). Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2707-z"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1473-3099(18)30162-2","article-title":"Dual antimicrobial therapy for gonorrhea: what is the role of azithromycin?","volume":"18","author":"Unemo","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","unstructured":"Centers for Disease Control and Prevention (2007). Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb. Mortal. Wkly. Rep., 56, 332\u2013336."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw864","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system","volume":"64","author":"Humphries","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Allan-Blitz, L.T., Hemarajata, P., Humphries, R.M., Kimble, M., Elias, S., and Klausner, J.D. (2018). Ciprofloxacin may be efficacious in treating wild-type Gyrase A genotype Neisseria gonorrhoeae infections. Sex. Transm. Dis., 45.","DOI":"10.1097\/OLQ.0000000000000758"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/jac\/dky090","article-title":"First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015\u201316","volume":"73","author":"Bazzo","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/sextrans-2012-050604","article-title":"Effectiveness of gentamicin for gonorrhea treatment systematic review and meta-analysis","volume":"88","author":"Dowell","year":"2012","journal-title":"Sex. Transm. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin. Infect. Dis."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/7\/3\/77\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:19:13Z","timestamp":1760195953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/7\/3\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["antibiotics7030077"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics7030077","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]}}}